Diurnal Group PLC (DNL)

London
58.00
0.00(0.00%)
  • Volume:
    95,745
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    58.00 - 58.00

DNL Overview

Prev. Close
58
Day's Range
58-58
Revenue
10.75M
Open
58
52 wk Range
47-97.97
EPS
-0.07
Volume
95,745
Market Cap
97.96M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
113,006
P/E Ratio
-
Beta
0.65
1-Year Change
-10.67%
Shares Outstanding
168,903,690
Next Earnings Date
01 Dec 2021
What is your sentiment on Diurnal Group PLC?
or
Market is currently closed. Voting is open during market hours.

Diurnal Group PLC News

Diurnal Group PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell

Diurnal Group PLC Company Profile

Diurnal Group PLC Company Profile

Employees
33

Diurnal Group plc is a clinical-stage pharmaceutical company. The Company is engaged in developing hormone therapeutics to aid treatment for various endocrine conditions. The Company's products include Chronocort, which is engaged in developing hydrocortisone product for the treatment of congenital adrenal hyperplasia and adrenal insufficiency; Infacort, which is engaged in creating paediatric hydrocortisone replacement product for neonates and infants suffering from adrenal insufficiency; Native Oral Testosterone, which is engaged in creating oral testosterone treatment for hypogonadism, and Tri4Combi, which is engaged in developing combination therapy product of thyroid hormones for patients suffering from hypothyroidism. The Company's products are under various clinical trials, including Chronocort, which is in Phase III clinical trial; Infacort, which is in Phase III clinical trial, and Native Oral Testosterone, which is in Phase I clinical trial.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.